Publications by authors named "Y Jamil"

Asthma is the most common chronic disease to affect pregnant women and can have a significant effect on pregnancy outcomes with increased rates of preterm birth, premature delivery and caesarean section observed if poorly controlled. Pregnancy can also influence asthma control. Prescribing in pregnancy causes anxiety for patients and healthcare professionals and can result in alteration or undertreatment of asthma.

View Article and Find Full Text PDF
Article Synopsis
  • Gram-negative bacteremia is a severe infection that is becoming more common and harder to treat due to antibiotic resistance, particularly in Lebanon where data is scarce.* -
  • A study of 2400 patients revealed that infections were mainly caused by bacteria like E. coli and Klebsiella pneumoniae, with increasing resistance to critical antibiotics like carbapenems.* -
  • The findings highlight the urgent need for better monitoring and data collection to improve treatment strategies for gram-negative bacteremia in Lebanon, as certain resistant strains are linked to higher mortality rates.*
View Article and Find Full Text PDF
Article Synopsis
  • Cardiac sarcoidosis (CS) is a serious condition that can lead to high rates of illness and death, and this study investigates its impact on patients hospitalized with COVID-19.
  • The research analyzed data from over 2.5 million COVID-19 cases, finding that CS patients were generally younger and had more comorbidities compared to those without CS, and they experienced a higher rate of in-hospital cardiac arrest before matching.
  • After matching, CS patients showed a significantly lower risk of acute kidney injury (AKI), but their rates of death, cardiac arrest, mechanical ventilation, and hospital stay length were similar to those without CS, indicating a need for further research on managing COVID-19 in CS patients.
View Article and Find Full Text PDF
Article Synopsis
  • - The study analyzed cardiovascular outcomes related to uric acid-lowering medications, finding no significant benefits for xanthine oxidase inhibitors (XOI) compared to placebo in terms of major cardiovascular events.
  • - The meta-analysis included 47 studies with over 3.8 million patients, showing that while there was no substantial difference in cardiovascular risks with XOI, Febuxostat may lower the risk of heart failure compared to Allopurinol.
  • - The researchers concluded that further studies are needed to confirm these findings, particularly the potential heart failure benefits of Febuxostat and the overall ineffectiveness of XOI in reducing cardiovascular events.
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how declines in cardiac function affect major adverse limb events (MALE) in patients who undergo lower extremity revascularization (LER) due to peripheral arterial disease (PAD).
  • Out of 926 patients analyzed, 24% experienced a decline in cardiac function, which was linked to higher rates of diabetes and heart failure but not to the method of revascularization.
  • Despite increased mortality rates over three years for those with cardiac function decline, there was no significant difference in limb-related outcomes or reintervention rates compared to patients with stable cardiac function.
View Article and Find Full Text PDF